These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35678886)

  • 21. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence Interval Within 1 Year Leads to Death in Patients with Grade 2 Meningioma.
    Ukai R; Wanibuchi M; Komatsu K; Kimura Y; Akiyama Y; Mikami T; Mikuni N
    World Neurosurg; 2020 Oct; 142():e58-e65. PubMed ID: 32454195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinicopathological analysis of receptor tyrosine kinases in meningiomas: the expression of VEGFR-2 in meningioma was associated with a higher WHO grade and shorter progression-free survival.
    Nakada S; Sasagawa Y; Tachibana O; Iizuka H; Kurose N; Shioya A; Guo X; Yamada S; Nojima T
    Brain Tumor Pathol; 2019 Jan; 36(1):7-13. PubMed ID: 30519894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
    Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
    J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of phosphatidylethanolamine-binding protein 4 (PEBP4) associates with recurrence of meningiomas.
    Huang RQ; Chen F; Jiang YB; Jin YM; Wang SQ; Liang HH; Chen ZP; Qian J
    Clin Neurol Neurosurg; 2022 Mar; 214():107148. PubMed ID: 35158167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of frozen section in determining meningioma subtype and grade.
    Prayson RA
    Ann Diagn Pathol; 2018 Aug; 35():7-10. PubMed ID: 30072016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
    J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
    Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
    Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
    Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
    Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of multimodality management for parasagittal meningiomas.
    Hua L; Wang D; Zhu H; Deng J; Luan S; Chen H; Sun S; Tang H; Xie Q; Wakimoto H; Gong Y
    J Neurooncol; 2020 Apr; 147(2):441-450. PubMed ID: 32088814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of a high-grade sarcoma in a recurrent meningioma: malignant progression or collision tumor?
    Oz B; Pekmezci M; Dashti R; Karaman K; Kuday C; Tihan T
    Arch Pathol Lab Med; 2011 Jul; 135(7):935-40. PubMed ID: 21732786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of STMN1 is associated with the prognosis of meningioma patients.
    Wang H; Li W; Wang G; Zhang S; Bie L
    Neurosci Lett; 2017 Jul; 654():1-5. PubMed ID: 28625575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
    Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
    J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
    Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
    J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdoid meningiomas: Clinicopathological analysis of a rare variant of meningioma.
    Birua GJS; Sadashiva N; Konar S; Rao S; Shukla D; Krishna U; Saini J; Santosh V
    Clin Neurol Neurosurg; 2021 Aug; 207():106778. PubMed ID: 34214868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.